Copyright Reports & Markets. All rights reserved.

Global IL-2R Agonist Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global IL-2R Agonist Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Protein Molecule
    • 1.3.3 Small Molecule
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global IL-2R Agonist Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Laboratory Research
  • 1.5 Global IL-2R Agonist Market Size & Forecast
    • 1.5.1 Global IL-2R Agonist Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global IL-2R Agonist Sales Quantity (2020-2031)
    • 1.5.3 Global IL-2R Agonist Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche IL-2R Agonist Product and Services
    • 2.1.4 Roche IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis IL-2R Agonist Product and Services
    • 2.2.4 Novartis IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer IL-2R Agonist Product and Services
    • 2.3.4 Pfizer IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi IL-2R Agonist Product and Services
    • 2.4.4 Sanofi IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sanofi Recent Developments/Updates
  • 2.5 AbbVie
    • 2.5.1 AbbVie Details
    • 2.5.2 AbbVie Major Business
    • 2.5.3 AbbVie IL-2R Agonist Product and Services
    • 2.5.4 AbbVie IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 AbbVie Recent Developments/Updates
  • 2.6 Bristol Myers Squibb
    • 2.6.1 Bristol Myers Squibb Details
    • 2.6.2 Bristol Myers Squibb Major Business
    • 2.6.3 Bristol Myers Squibb IL-2R Agonist Product and Services
    • 2.6.4 Bristol Myers Squibb IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Bristol Myers Squibb Recent Developments/Updates
  • 2.7 Merck KGaA
    • 2.7.1 Merck KGaA Details
    • 2.7.2 Merck KGaA Major Business
    • 2.7.3 Merck KGaA IL-2R Agonist Product and Services
    • 2.7.4 Merck KGaA IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Merck KGaA Recent Developments/Updates
  • 2.8 Johnson & Johnson
    • 2.8.1 Johnson & Johnson Details
    • 2.8.2 Johnson & Johnson Major Business
    • 2.8.3 Johnson & Johnson IL-2R Agonist Product and Services
    • 2.8.4 Johnson & Johnson IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Johnson & Johnson Recent Developments/Updates
  • 2.9 Merck
    • 2.9.1 Merck Details
    • 2.9.2 Merck Major Business
    • 2.9.3 Merck IL-2R Agonist Product and Services
    • 2.9.4 Merck IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Merck Recent Developments/Updates
  • 2.10 China Biological Pharmacy Group
    • 2.10.1 China Biological Pharmacy Group Details
    • 2.10.2 China Biological Pharmacy Group Major Business
    • 2.10.3 China Biological Pharmacy Group IL-2R Agonist Product and Services
    • 2.10.4 China Biological Pharmacy Group IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 China Biological Pharmacy Group Recent Developments/Updates
  • 2.11 Roche Diagnostics
    • 2.11.1 Roche Diagnostics Details
    • 2.11.2 Roche Diagnostics Major Business
    • 2.11.3 Roche Diagnostics IL-2R Agonist Product and Services
    • 2.11.4 Roche Diagnostics IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Roche Diagnostics Recent Developments/Updates
  • 2.12 AstraZeneca
    • 2.12.1 AstraZeneca Details
    • 2.12.2 AstraZeneca Major Business
    • 2.12.3 AstraZeneca IL-2R Agonist Product and Services
    • 2.12.4 AstraZeneca IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 AstraZeneca Recent Developments/Updates
  • 2.13 Abbott Laboratories
    • 2.13.1 Abbott Laboratories Details
    • 2.13.2 Abbott Laboratories Major Business
    • 2.13.3 Abbott Laboratories IL-2R Agonist Product and Services
    • 2.13.4 Abbott Laboratories IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Abbott Laboratories Recent Developments/Updates
  • 2.14 Shenzhen Mindray Bio-Medical Electronics
    • 2.14.1 Shenzhen Mindray Bio-Medical Electronics Details
    • 2.14.2 Shenzhen Mindray Bio-Medical Electronics Major Business
    • 2.14.3 Shenzhen Mindray Bio-Medical Electronics IL-2R Agonist Product and Services
    • 2.14.4 Shenzhen Mindray Bio-Medical Electronics IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments/Updates
  • 2.15 Bloomage Biotechnology Corporation
    • 2.15.1 Bloomage Biotechnology Corporation Details
    • 2.15.2 Bloomage Biotechnology Corporation Major Business
    • 2.15.3 Bloomage Biotechnology Corporation IL-2R Agonist Product and Services
    • 2.15.4 Bloomage Biotechnology Corporation IL-2R Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Bloomage Biotechnology Corporation Recent Developments/Updates

3 Competitive Environment: IL-2R Agonist by Manufacturer

  • 3.1 Global IL-2R Agonist Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global IL-2R Agonist Revenue by Manufacturer (2020-2025)
  • 3.3 Global IL-2R Agonist Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of IL-2R Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 IL-2R Agonist Manufacturer Market Share in 2024
    • 3.4.3 Top 6 IL-2R Agonist Manufacturer Market Share in 2024
  • 3.5 IL-2R Agonist Market: Overall Company Footprint Analysis
    • 3.5.1 IL-2R Agonist Market: Region Footprint
    • 3.5.2 IL-2R Agonist Market: Company Product Type Footprint
    • 3.5.3 IL-2R Agonist Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global IL-2R Agonist Market Size by Region
    • 4.1.1 Global IL-2R Agonist Sales Quantity by Region (2020-2031)
    • 4.1.2 Global IL-2R Agonist Consumption Value by Region (2020-2031)
    • 4.1.3 Global IL-2R Agonist Average Price by Region (2020-2031)
  • 4.2 North America IL-2R Agonist Consumption Value (2020-2031)
  • 4.3 Europe IL-2R Agonist Consumption Value (2020-2031)
  • 4.4 Asia-Pacific IL-2R Agonist Consumption Value (2020-2031)
  • 4.5 South America IL-2R Agonist Consumption Value (2020-2031)
  • 4.6 Middle East & Africa IL-2R Agonist Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global IL-2R Agonist Sales Quantity by Type (2020-2031)
  • 5.2 Global IL-2R Agonist Consumption Value by Type (2020-2031)
  • 5.3 Global IL-2R Agonist Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global IL-2R Agonist Sales Quantity by Application (2020-2031)
  • 6.2 Global IL-2R Agonist Consumption Value by Application (2020-2031)
  • 6.3 Global IL-2R Agonist Average Price by Application (2020-2031)

7 North America

  • 7.1 North America IL-2R Agonist Sales Quantity by Type (2020-2031)
  • 7.2 North America IL-2R Agonist Sales Quantity by Application (2020-2031)
  • 7.3 North America IL-2R Agonist Market Size by Country
    • 7.3.1 North America IL-2R Agonist Sales Quantity by Country (2020-2031)
    • 7.3.2 North America IL-2R Agonist Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe IL-2R Agonist Sales Quantity by Type (2020-2031)
  • 8.2 Europe IL-2R Agonist Sales Quantity by Application (2020-2031)
  • 8.3 Europe IL-2R Agonist Market Size by Country
    • 8.3.1 Europe IL-2R Agonist Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe IL-2R Agonist Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific IL-2R Agonist Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific IL-2R Agonist Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific IL-2R Agonist Market Size by Region
    • 9.3.1 Asia-Pacific IL-2R Agonist Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific IL-2R Agonist Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America IL-2R Agonist Sales Quantity by Type (2020-2031)
  • 10.2 South America IL-2R Agonist Sales Quantity by Application (2020-2031)
  • 10.3 South America IL-2R Agonist Market Size by Country
    • 10.3.1 South America IL-2R Agonist Sales Quantity by Country (2020-2031)
    • 10.3.2 South America IL-2R Agonist Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa IL-2R Agonist Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa IL-2R Agonist Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa IL-2R Agonist Market Size by Country
    • 11.3.1 Middle East & Africa IL-2R Agonist Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa IL-2R Agonist Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 IL-2R Agonist Market Drivers
  • 12.2 IL-2R Agonist Market Restraints
  • 12.3 IL-2R Agonist Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of IL-2R Agonist and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of IL-2R Agonist
  • 13.3 IL-2R Agonist Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 IL-2R Agonist Typical Distributors
  • 14.3 IL-2R Agonist Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global IL-2R Agonist market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    IL-2R agonists, namely Interleukin-2 Receptor (IL-2R for short) agonists, are a class of drugs or compounds that can activate IL-2R. IL-2R is a specific receptor for interleukin-2 (IL-2), which is mainly expressed on immune cells such as T lymphocytes, NK cells, and B lymphocytes. As an important immunoregulatory factor, IL-2 has various biological activities such as promoting T cell proliferation, enhancing NK cell activity, and inducing B cell differentiation. However, the activity of IL-2 in vivo is regulated by different subtypes of IL-2R, especially IL-2R αβγ trimers and IL-2R βγ dimers respond differently to IL-2. Therefore, designing agonists that can selectively activate specific IL-2R subtypes is of great significance for accurately regulating immune responses.
    As the technology gradually matures, the industry has found some methods and approaches to enhance the activation of cytotoxic T lymphocytes (CTLs) by IL-2 while reducing or blocking the activation of regulatory T cells (Tregs). This progression is achieved by enhancing IL-2's affinity for IL-2R βγ dimers while simultaneously weakening its affinity for IL-2R αβγ trimers or IL-2R alpha. Overall, the IL-2R agonist market has broad development prospects.
    This report is a detailed and comprehensive analysis for global IL-2R Agonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global IL-2R Agonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global IL-2R Agonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global IL-2R Agonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global IL-2R Agonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for IL-2R Agonist
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global IL-2R Agonist market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Pfizer, Sanofi, AbbVie, Bristol Myers Squibb, Merck KGaA, Johnson & Johnson, Merck, China Biological Pharmacy Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    IL-2R Agonist market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Protein Molecule
    Small Molecule
    Market segment by Application
    Pharmaceutical Industry
    Laboratory Research
    Major players covered
    Roche
    Novartis
    Pfizer
    Sanofi
    AbbVie
    Bristol Myers Squibb
    Merck KGaA
    Johnson & Johnson
    Merck
    China Biological Pharmacy Group
    Roche Diagnostics
    AstraZeneca
    Abbott Laboratories
    Shenzhen Mindray Bio-Medical Electronics
    Bloomage Biotechnology Corporation
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe IL-2R Agonist product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of IL-2R Agonist, with price, sales quantity, revenue, and global market share of IL-2R Agonist from 2020 to 2025.
    Chapter 3, the IL-2R Agonist competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the IL-2R Agonist breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and IL-2R Agonist market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of IL-2R Agonist.
    Chapter 14 and 15, to describe IL-2R Agonist sales channel, distributors, customers, research findings and conclusion.

    Buy now